On the agenda of the plenary meeting of the European Parliament for Tuesday 18 October is a draft motion for a resolution, objecting against the extension of the approval period of several substances.
Resolution against flutianil MRLs in EP plenary
The motion for a resolution objecting against the setting of import tolerances for flutianil, adopted in the ENVI Committee meeting on 15.03.2022 is now programmed for the plenary meeting of the...
Resolution against flutianil MRLs adopted in ENVI Committee
The ENVI Committee of the European Parliament adopted on 15.03.2022 a motion for a resolution objecting against the setting of MRLs for flutianil.
Draft objection against MRL Resolution rejected
A draft motion for a resolution, objecting against the setting of new MRLs for flonicamid, was rejected by the ENVI Committee.
ENVI Committee adopts draft objection against approval extensions
The ENVI Committee adopted a draft motion for a resolution, objecting against the recent extension of approvals of active substances.
Draft motion for resolution, objection extensions chlorotoluron and difenoconazole
On the agenda of the ENVI Committee for the meeting of 27.09.2021 is a draft motion for a resolution objecting against the extension of the approval periods for cholorotoluron and difenoconazole.
Parliament adopts two pesticide-related resolutions
The European Parliament, in the session of 09.06.2021 of the plenary meeting in Strasbourg, adopted two resolutions, relating to imidacloprid and flumioxazin.
Draft EP resolution against extension of flumioxazin approval
A draft motion for a resolution was published by the European Parliament, objecting against the Commission implementing Regulation extending the approval period of (i.a.) flumioxazin.
Parliament ENVI Committee adopts draft Resolutions against MRL Regulations
The ENVI Committee of the European Parliament voted in favour of two draft resolutions objecting against MRL Regulations.
EP ENVI: draft motions for resolutions against MRLs published
On 13.04.2021, two days before the ENVI Committee meeting, three motions for resolutions objecting against MRL Regulations were published.
EP ENVI Committee keeps targeting MRL Regulations
On the agenda of the ENVI Committee for 15-16 April several new draft resolutions are listed, targeting MRL Regulations in the scrutiny period.
EP draft objection extension of dimoxystrobin approval
On 23.02.2021 the ENVI Committee published a draft resolution objecting against a Regulation extending the approval periods of 9 substances.
ENVI Committee rejects 3 draft resolutions against MRL Regulations
On 10.12.2020 three draft resolutions were discussed and voted in the ENVI-Committee of the European Parliament.
New EP Resolutions against 3 draft MRL Regulations
In the European Parliament objections were logged in the scrutiny procedures of 3 new MRL Regulations.
EP votes on the resolution against extension of chlorotoluron
Today, 24.11.2020, the plenary meeting of the European Parliament will vote on the motion for a resolution against the extension of the approval of chlorotoluron
New EP draft resolutions published
The draft motions for resolution, announced on 03..09.2020, are now published as documents for the meeting of the ENVI Committee of 16.01.2020
Resolution against MRL Regulation on agenda plenary meeting EP
On the agenda of the plenary meeting of the European Parliament, for the session of Thursday 17.09.2020, is the vote on a draft Resolution, objecting against a Commission Regulation setting MRLs.
EP motion for resolution, objection extension 26 substances incl. flumioxazin
On 03.07.2020 the European Parliament published the motion for a resolution objecting against the draft [sic] Commission implementing regulation extending the approval periods of 26 active substances.
EP resolution against extension flumioxazin in plenary meeting
The European Parliament published the draft agenda for the next plenary meeting.
ENVI Committee meeting of 8 June 2020
In the European Parliament’s ENVI Committee meeting of 8 June 2020, a motion for a resolution against the extension of flumioxazin will be discussed and voted.